FF-10832

· Fujifilm Pharmaceuticals U.S.A., Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for FF-10832, covering 2025-05-18 to 2025-09-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate Safety, Efficacy of FF-10832 in Combo With Pembrolizumab in Urothelial & Non-small Cell Lung Cancer [Phase 2]

See pricing